Riverpark at Alexandria Center for the Life Sciences
430 E 29th Street
New York, NY 10016
They grew up in Brooklyn. Queens. The Bronx. Staten Island. They became top scientists, and eventually life sciences entrepreneurs. And like many others before them, they rose to biopharma prominence only after leaving New York.
They're the New York expats, and to many in the New York life sciences scene, they're seen as key to the area's ambitions to nurture and grow its biotech sector--if they'll only come back and lead companies in the Big Apple.
For one evening, Xconomy is going to make that happen. Xconomy is bringing together a few biopharma leaders who are ex-New Yorkers to lead a unique, candid discussion with the local biotech community. Why did they leave New York? What do they make of their former home from afar? And what would entice them, and others like them, to take a shot on a New York company?
Confirmed speakers include:
- Steve Holtzman, President & CEO, Decibel Therapeutics
- Jeremy Levin, CEO & Chairman of the Board, Ovid Therapeutics
- David Epstein, Executive Partner, Flagship Pioneering
- Jenna Foger, Senior Vice President - Science & Technology, Alexandria Venture Investments